More on anemia drugs

From the L.A. Times article:

The largest group of U.S. cancer doctors said Monday that Medicare has gone too far in restricting the use of anemia drugs made by Amgen Inc. and Johnson & Johnson and released its own guidelines.

The doctors' recommendations add new warnings about heart risks while saying patients can safely use higher doses than Medicare allows. The guidelines, based on a three-year review of clinical trials, are being published by the American Society of Clinical Oncology, an association of cancer doctors, and the American Society of Hematology, a group of blood experts.

Click here to access the article.